CTU Bern (Clinical Trials Unit)

SCTO - Regulatory Affairs Watch

Hot off the press, issue 1!
Dear clinical research investigators, partners, and friends,
The Swiss Clinical Trial Organisation is delighted to share with you the first issue of Regulatory Affairs Watch.

This newsletter is a result of a collaborative initiative from the SCTO Regulatory Affairs Platform that brings together regulatory experts from our CTU Network and from the SAKK (Swiss Group for Clinical Cancer Research).
The Regulatory Affairs Platform strives to deliver regular updates on key human research-related, regulatory topics, news, and events to a broad audience of stakeholders. This first issue is devoted to the hot topic of data protection, looking at the potential impact in Switzerland of the recent European General Data Protection Regulation (GDPR).
Enjoy reading this first issue of RA Watch!  We encourage you to subscribe to receive forthcoming issues and to share this freely with colleagues. 
With our very best wishes,
Prof. Christiane Pauli-Magnus, President of the SCTO and 
Dr Laure Valloton, Regulatory Affairs Platform Coordinator

Highlights from issue 1

  • WELCOME to RA Watch... and to the world of data protection 
  • DEEP DIVE: The EU GDPR and clinical research
  • VIEWS AND OPINIONS
  • HEADLINES AND HAPPENINGS
  • EVENTS AND PUBLICATIONS